Charles Dadswell has stepped down as Illumina's general counsel but will advise CEO Jacob Thaysen and the board through early ...

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the ...

In this article, we summarise the key points you should consider when deciding which sequencing method is best for your ...

Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the ...

The overall sequencing output of the Illumina GA system is more than 1 billion ... The template-dependent incorporation of single dye-labeled nucleotide is imaged with a CCD camera to make a ...

We came across a bullish thesis on Illumina, Inc. (ILMN) on Ocean Road Capital’s Substack by Ocean Road Capital. In this ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of DNA sequencing and array-based technologies, finds itself at a critical juncture as it navigates a shifting competitive landscape while striving ...

By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership ...

For the second year in a row, Illumina’s Singapore team participated in the annual overnight Relay for Life Charity Run for ...

Dadswell joined the company as General Counsel in 2013, following a distinguished career providing legal counsel to the biotechnology sector. Most recently, he oversaw the company's successful ...

Illumina is a US-based company that has established itself as a global leader in DNA sequencing and array-based technologies. In September 2021, the US company Grail announced it had accepted an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...